CD44 and neoplasm: As most of the CD8+ T cells in tumor-experienced brains were CD44+ memory T cells, while the CD8+ T cells in peripheral tissue were not, we then compared the antitumor effect of CD44+CD8+ T cells in brain, dLNs, peripheral LNs, and PB to validate the results.